Profilin-1 is expressed in human atherosclerotic plaques and induces atherogenic effects on vascular smooth muscle cells

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Caglayan, Evren ^a   Romeo, Giulio R ^b   Kappert, Kai ^c   Odenthal, Margarete ^a   Südkamp, Michael ^d   Body, Simon C ^e   Shernan, Stanton K ^e   Hackbusch, Daniel ^c   Vantler, Marius ^a   Kazlauskas, Andrius ^f   Rosenkranz, Stephan ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b JOSLIN DIABETES CENTER   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 2,3 DIHYDRO 2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 1H INDOLE 5 SULFONIC ACID DIMETHYLAMIDE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; DNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROFILIN; PROFILIN I; PROTEIN KINASE B; RECOMBINANT PROFILIN 1; RECOMBINANT PROTEIN; S6 KINASE; UNCLASSIFIED DRUG; WORTMANNIN; PFN1 PROTEIN, HUMAN; PRIMER DNA;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; AUTOCRINE EFFECT; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL STIMULATION; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; DNA SYNTHESIS; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PARACRINE SIGNALING; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL CULTURE; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; POLYMERASE CHAIN REACTION; WISTAR KYOTO RAT;

RATTUS;

ANIMALS; ATHEROSCLEROSIS; BASE SEQUENCE; CELLS, CULTURED; DNA PRIMERS; HUMANS; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROFILINS; RATS; RATS, INBRED WKY; SIGNAL TRANSDUCTION;

EID: 78149423199     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013608     Document Type: Article

References (28)

1. Suzuki LA, Poot M, Gerrity RG, Bornfeldt KE (2001) Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growthpromoting effects of high glucose levels. Diabetes 50: 851-860.
2. Dandona P, Aljada A, Chaudhuri A, Bandyopadhyay A (2003) The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes. J Clin Endocrinol Metab 88: 2422-2429.
3. Hsueh WA, Quinones MJ (2003) Role of endothelial dysfunction in insulin resistance. Am J Cardiol 92: 10J-17J.
4. Libby P (2002) Inflammation in atherosclerosis. Nature 420: 868-874.
5. Waltenberger J, Lange J, Kranz A (2000) Vascular endothelial growth factor-Ainduced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals. Circulation 102: 185-190.
6. Marx N, Walcher D, Raichle C, Aleksic M, Bach H, et al. (2004) C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro. Arterioscler Thromb Vasc Biol 24: 540-545.
7. Walcher D, Babiak C, Poletek P, Rosenkranz S, Bach H, et al. (2006) C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2. Circ Res 99: 1181-1187.
8. Romeo G, Frangioni JV, Kazlauskas A (2004) Profilin acts downstream of LDL to mediate diabetic endothelial cell dysfunction. FASEB J 18: 725-727.
9. Romeo GR, Moulton KS, Kazlauskas A (2007) Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse. Circ Res 101: 357-367.
10. Kwiatkowski DJ, Bruns GA (1988) Human profilin. Molecular cloning, sequence comparison, and chromosomal analysis. J Biol Chem 263: 5910-5915.
11. Paavilainen VO, Bertling E, Falck S, Lappalainen P (2004) Regulation of cytoskeletal dynamics by actin-monomer-binding proteins. Trends Cell Biol 14: 386-394.
12. Yarmola EG, Bubb MR (2006) Profilin: emerging concepts and lingering misconceptions. Trends Biochem Sci 31: 197-205.
13. Machesky LM, Poland TD (1993) Profilin as a potential mediator of membranecytoskeleton communication. Trends Cell Biol 3: 381-385.
14. Tamura M, Tanaka H, Yashiro A, Osajima A, Okazaki M, et al. (2000) Expression of profilin, an actin-binding protein, in rat experimental glomerulonephritis and its upregulation by basic fibroblast growth factor in cultured rat mesangial cells. J Am Soc Nephrol 11: 423-433.
15. Tamura M, Yanagihara N, Tanaka H, Osajima A, Hirano T, et al. (2000) Activation of DNA synthesis and AP-1 by profilin, an actin-binding protein, via binding to a cell surface receptor in cultured rat mesangial cells. J Am Soc Nephrol 11: 1620-1630.
16. Chamley-Campbell J, Campbell GR, Ross R (1979) The smooth muscle cell in culture. Physiol Rev 59: 1-61.
17. Rosenkranz S, DeMali KA, Gelderloos JA, Bazenet C, Kazlauskas A (1999) Identification of the receptor-associated signaling enzymes that are required for platelet-derived growth factor-AA-dependent chemotaxis and DNA synthesis. J Biol Chem 274: 28335-28343.
18. Rosenkranz S, Knirel D, Dietrich H, Flesch M, Erdmann E, et al. (2002) Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the ''French paradox''. FASEB J 16: 1958-1960.
19. Caglayan E, Stauber B, Collins AR, Lyon CJ, Yin F, et al. (2008) Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis. Diabetes 57: 2470-2479.
20. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339: 229-234.
21. Hsueh WA, Bruemmer D (2004) Peroxisome proliferator-activated receptor gamma: implications for cardiovascular disease. Hypertension 43: 297-305.
22. Haugwitz M, Noegel AA, Karakesisoglou J, Schleicher M (1994) Dictyostelium amoebae that lack G-actin-sequestering profilins show defects in F-actin content, cytokinesis, and development. Cell 79: 303-314.
23. Witke W (2004) The role of profilin complexes in cell motility and other cellular processes. Trends Cell Biol 14: 461-469.
24. Witke W, Sutherland JD, Sharpe A, Arai M, Kwiatkowski DJ (2001) Profilin I is essential for cell survival and cell division in early mouse development. Proc Natl Acad Sci U S A 98: 3832-3836.
25. Moustafa-Bayoumi M, Alhaj MA, El-Sayed O, Wisel S, Chotani MA, et al. (2007) Vascular hypertrophy and hypertension caused by transgenic overexpression of profilin 1. J Biol Chem 282: 37632-37639.
26. Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, et al. (2005) TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308: 1626-1629.
27. Bromann PA, Korkaya H, Courtneidge SA (2004) The interplay between Src family kinases and receptor tyrosine kinases. Oncogene 23: 7957-7968.
28. Tallquist M, Kazlauskas A (2004) PDGF signaling in cells and mice. Cytokine Growth Factor Rev 15: 205-213.